Mitochondrial disease: clinical aspects, molecular mechanisms, translational science, and clinical frontiers

J Child Neurol. 2014 Sep;29(9):1179-207. doi: 10.1177/0883073814537379. Epub 2014 Jun 9.

Abstract

Mitochondrial medicine provides a metabolic perspective on the pathology of conditions linked with inadequate oxidative phosphorylation. Dysfunction in the mitochondrial machinery can result in improper energy production, leading to cellular injury or even apoptosis. Clinical presentations are often subtle, so clinicians must have a high index of suspicion to make early diagnoses. Symptoms could include muscle weakness and pain, seizures, loss of motor control, decreased visual and auditory functions, metabolic acidosis, acute developmental regression, and immune system dysfunction. The 2013 Neurobiology of Disease in Children Symposium, held in conjunction with the 42nd Annual Meeting of the Child Neurology Society, aimed to (1) describe accepted clinical phenotypes of mitochondrial disease produced from various mitochondrial mutations, (2) discuss contemporary understanding of molecular mechanisms that contribute to disease pathology, (3) highlight the systemic effects produced by dysfunction within the mitochondrial machinery, and (4) introduce current strategies that are being translated from bench to bedside as potential therapeutics.

Keywords: mitochondrial disease.

Publication types

  • Congress

MeSH terms

  • Animals
  • Child
  • Humans
  • Mitochondria / genetics
  • Mitochondria / physiology
  • Mitochondrial Diseases / diagnosis
  • Mitochondrial Diseases / genetics
  • Mitochondrial Diseases / physiopathology*
  • Mitochondrial Diseases / therapy*
  • Neurobiology
  • Societies, Medical